[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
July 1976

Respiratory Paralysis During Treatment of Hypertension With Trimethaphan Camsylate

Arch Intern Med. 1976;136(7):816-818. doi:10.1001/archinte.1976.03630070060018

Four cases are reported in which respiratory arrest occurred coincident with the intravenous administration of large doses of trimethaphan camsylate (Arfonad) to control hypertension. The mechanism of the respiratory depression is unknown, but it may have been related to a direct effect of trimethaphan on the respiratory center or to a curare-like effect of the drug. Close monitoring of ventilatory capacity should be maintained in all patients treated with trimethaphan.

(Arch Intern Med 136:816-818, 1976)